{"id":52862,"date":"2023-01-12T17:02:12","date_gmt":"2023-01-12T16:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/"},"modified":"2023-01-12T17:02:12","modified_gmt":"2023-01-12T16:02:12","slug":"patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/","title":{"rendered":"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5410432\/the-corporate-reputation-of-pharma-in-2021-the?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=57cnxd&amp;utm_campaign=1807032+-+Patient+Perspective+of+151+German+Patient+Groups++on+the+Corporate+Reputation+of+Pharma&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;The Corporate Reputation of Pharma in 2021- The Patient Perspective &#8211; Germany Edition &#8211; The Views of 151 German Patient Groups&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe &#8216;Corporate Reputation of Pharma&#8217; survey &#8211; the 2021 Germany edition is now in its 10th year, and two years into the Covid-19 pandemic). Between November 2021-February 2022, the survey collected the opinions of 151 German patient groups on the performance of the pharmaceutical industry during 2021.\n<\/p>\n<p>\nPatient groups responding to the &#8216;Corporate Reputation of Pharma&#8217; survey are uniquely positioned to comment on the pharma industry&#8217;s performance during the pandemic. Patient groups not only understand the perceptions of patients, but are also the only healthcare stakeholder to network with all other stakeholders in the healthcare system.\n<\/p>\n<p>\n<strong>The report provides details on:<\/strong>\n<\/p>\n<ul>\n<li>\nHow the analyst measures pharma&#8217;s corporate reputation from a patient perspective;\n<\/li>\n<li>\nThe headline results of the 2021 Germany element of the &#8216;Corporate Reputation&#8217; survey;\n<\/li>\n<li>\nThe companies included in the 2021 Germany analysis; and\n<\/li>\n<li>\nThe profiles of 2021&#8217;s respondent German patient groups.\n<\/li>\n<\/ul>\n<p>\n<strong>Company Rankings in 2021<\/strong>\n<\/p>\n<ul>\n<li>\nThe top-three pharma companies in Germany in 2021, out of 24 companies, ranked for their overall corporate reputation (as assessed by respondent German patient groups familiar with the company): ViiV Healthcare, 1st &#8211; Pfizer, 2nd &#8211; MSD*, 3rd. (*known as Merck &amp; Co in Canada and the United States)\n<\/li>\n<li>\nThe top-three pharma companies in Germany in 2021, out of 15 companies, ranked for their overall corporate reputation (as assessed by respondent German patient groups working with the company): ViiV Healthcare, 1st &#8211; Pfizer, 2nd &#8211; AstraZeneca, 3rd.\n<\/li>\n<li>\nThe top-three &#8216;big-pharma&#8217; companies in Germany in 2021, out of 13 &#8216;big-pharma&#8217; companies, ranked for their overall corporate reputation (as assessed by respondent German patient groups familiar with the company): Pfizer, 1st &#8211; MSD, 2nd &#8211; Roche, 3rd.\n<\/li>\n<\/ul>\n<p>\n<strong>Each company is profiled by the following measures:<\/strong>\n<\/p>\n<ul>\n<li>\nThe number of respondent German patient groups familiar, and working, with the company, 2021.\n<\/li>\n<li>\nThe profile of the respondent German patient groups familiar with the company (the number of patients reached; specialties; and geographic remit), 2021.\n<\/li>\n<li>\nThe types of relationships that the company had with its respondent German patient group partners, 2021. Company performance in Germany at the individual indicators of corporate reputation in 2021- as assessed by respondent German patient groups familiar, and working, with the company. Competitors&#8217; relationships in 2021 with the company&#8217;s respondent German patient group partners.\n<\/li>\n<li>\nOverall rankings in Germany for the company- as assessed by respondent German patient groups familiar, and working, with the company, 2021 v. 2020.\n<\/li>\n<li>\nCompany rankings in Germany for each of the indicators- as assessed by respondent German patient groups familiar, and working, with the company, 2021 v. 2020.\n<\/li>\n<li>\nSnapshot view: where the company sits in the corporate tiers in Germany for each of the indicators (in the higher, the middle, or the lower tier)- as assessed by respondent German patient groups familiar, and working, with the company, 2021.\n<\/li>\n<li>\nOverall rankings of the company in Germany, 2015-2021- expressed on the Patient Corporate Reputation Index (PCRI), a measure designed to standardise the analyst&#8217;s ranking data (preventing results being skewed by the differing numbers of companies included in Germany&#8217;s historic analyses over the various years). PCRI ranking is from 0 to 1, with 1 being the best (the highest rank)- as assessed by respondent German patient groups familiar with the company.\n<\/li>\n<\/ul>\n<p>\n<strong>Profiles of the 24 companies, 2021<\/strong>\n<\/p>\n<ul>\n<li>\nAbbVie\n<\/li>\n<li>\nAmgen\n<\/li>\n<li>\nAstraZeneca\n<\/li>\n<li>\nBayer\n<\/li>\n<li>\nBiogen\n<\/li>\n<li>\nBoehringer Ingelheim\n<\/li>\n<li>\nBristol Myers Squibb\n<\/li>\n<li>\nCSL Behring\n<\/li>\n<li>\nEli Lilly\n<\/li>\n<li>\nGilead Sciences\n<\/li>\n<li>\nGrunenthal\n<\/li>\n<li>\nGSK\n<\/li>\n<li>\nJanssen\n<\/li>\n<li>\nMerck KGaA\n<\/li>\n<li>\nMSD\n<\/li>\n<li>\nMylan\n<\/li>\n<li>\nNovartis\n<\/li>\n<li>\nNovo Nordisk\n<\/li>\n<li>\nPfizer\n<\/li>\n<li>\nRoche\n<\/li>\n<li>\nSandoz\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTakeda\n<\/li>\n<li>\nViiV Healthcare\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<ul>\n<li>\nExecutive summary\n<\/li>\n<li>\nRelationships that German patient groups have with pharma, 2021\n<\/li>\n<li>\nIndustry-wide findings in Germany, 2021\n<\/li>\n<li>\nRankings of 24 pharma companies in Germany, 2021 v. 2020, as assessed by respondent German patient groups familiar with the companies\n<\/li>\n<li>\nRankings of 15 pharma companies in Germany, 2021 v. 2020, as assessed by respondent German patient groups working with the companies\n<\/li>\n<li>\nRankings of 13 &#8216;big-pharma&#8217; companies in Germany, 2021 v. 2020, as assessed by respondent German patient groups familiar with the companies\n<\/li>\n<li>\nRankings of 12 &#8216;big-pharma&#8217; companies in Germany, 2021 v. 2020, as assessed by respondent German patient groups working with the companies\n<\/li>\n<li>\nProfiles of the 24 companies, 2021 (v. 2020)\n<\/li>\n<\/ul>\n<p>\n<strong>Appendices<\/strong>\n<\/p>\n<p>\nI. Profiles of respondent German patient groups, 2021\n<\/p>\n<p>\nII. List of respondent German patient groups that wished to be attributed, 2021\n<\/p>\n<p>\nIII. Commentaries and feedback from respondent German patient groups on how pharma can improve, 2021-2022\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5410432\/the-corporate-reputation-of-pharma-in-2021-the?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=57cnxd&amp;utm_campaign=1807032+-+Patient+Perspective+of+151+German+Patient+Groups++on+the+Corporate+Reputation+of+Pharma&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/ied40s<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;&#112;&#x72;&#101;&#x73;&#115;&#64;&#x72;e&#x73;e&#x61;&#114;&#x63;&#104;&#x61;&#110;&#x64;&#109;a&#x72;k&#x65;t&#x73;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#x73;&#x73;&#64;&#x72;e&#115;&#x65;&#97;&#x72;c&#104;&#x61;n&#x64;m&#97;&#x72;k&#x65;&#x74;&#115;&#x2e;c&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;The Corporate Reputation of Pharma in 2021- The Patient Perspective &#8211; Germany Edition &#8211; The Views of 151 German Patient Groups&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The &#8216;Corporate Reputation of Pharma&#8217; survey &#8211; the 2021 Germany edition is now in its 10th year, and two years into the Covid-19 pandemic). Between &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52862","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;The Corporate Reputation of Pharma in 2021- The Patient Perspective &#8211; Germany Edition &#8211; The Views of 151 German Patient Groups&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The &#8216;Corporate Reputation of Pharma&#8217; survey &#8211; the 2021 Germany edition is now in its 10th year, and two years into the Covid-19 pandemic). Between ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-12T16:02:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-01-12T16:02:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/\"},\"wordCount\":819,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005601\\\/en\\\/1684668\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/\",\"name\":\"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005601\\\/en\\\/1684668\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-01-12T16:02:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005601\\\/en\\\/1684668\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005601\\\/en\\\/1684668\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;The Corporate Reputation of Pharma in 2021- The Patient Perspective &#8211; Germany Edition &#8211; The Views of 151 German Patient Groups&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The &#8216;Corporate Reputation of Pharma&#8217; survey &#8211; the 2021 Germany edition is now in its 10th year, and two years into the Covid-19 pandemic). Between ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-12T16:02:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma &#8211; ResearchAndMarkets.com","datePublished":"2023-01-12T16:02:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/"},"wordCount":819,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/","name":"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/21\/logo.jpg","datePublished":"2023-01-12T16:02:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230112005601\/en\/1684668\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/patient-perspective-of-151-german-patient-groups-on-the-corporate-reputation-of-pharma-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52862"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52862\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}